Company: ZVRA
Filing Date: 2025-04-07
Form Type: 8-K
Source: 0001193125-25-073991
Chunk: 1

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-04-07
Form: 8-K
Item: Item 2.02
Chunk 1
---
Item 2.02      Results of Operations and Financial Condition.  

On April 7, 2025, the Company issued a press release in relation to the Asset Sale, in which the Company announced that as of March 31, 2025, the Company’s cash, cash equivalents and investments were approximately $68.7 million. The press release is attached to this Current Report on Form8-Kas Exhibit 99.1.

The information contained in this item, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.